Matches in Wikidata for { <http://www.wikidata.org/entity/Q92128926> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q92128926 description "article scientifique publié en 2019" @default.
- Q92128926 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92128926 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92128926 description "scientific article published on 13 June 2019" @default.
- Q92128926 description "wetenschappelijk artikel" @default.
- Q92128926 description "наукова стаття, опублікована 13 червня 2019" @default.
- Q92128926 name "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 name "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 type Item @default.
- Q92128926 label "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 label "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 prefLabel "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 prefLabel "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 P1433 Q92128926-94C53811-7E10-4130-B885-D5340BB5CE61 @default.
- Q92128926 P1476 Q92128926-C026ED3F-12A5-48D2-B551-FBFED08460BC @default.
- Q92128926 P2093 Q92128926-2E4C9BB7-A55B-4F55-9014-A5B03B9A7FE8 @default.
- Q92128926 P2093 Q92128926-32E750C3-3CD0-4E97-A638-51157309B69D @default.
- Q92128926 P2093 Q92128926-54836F71-0D0D-4E37-85C6-49D39F7E1065 @default.
- Q92128926 P2093 Q92128926-5EFC92E3-D9D5-4FFE-89C4-D2B6687E8FD3 @default.
- Q92128926 P2093 Q92128926-5FE06A90-00CA-4E54-9557-A0CF4A64DE73 @default.
- Q92128926 P2093 Q92128926-75DD6F17-BBE4-48EA-B22C-C111FE1BDC04 @default.
- Q92128926 P2093 Q92128926-ACABF99B-4A6B-45E3-9DCB-8304AF2430B8 @default.
- Q92128926 P2093 Q92128926-BFC8C85E-3D39-4513-9D3B-C1A394D4D6F1 @default.
- Q92128926 P2860 Q92128926-0AEFBC4C-DD5F-4DB8-A30B-BC2C1E9C8A19 @default.
- Q92128926 P2860 Q92128926-0DD68B18-BC3A-40C3-A654-35A67D14E525 @default.
- Q92128926 P2860 Q92128926-195E8AB6-1EE0-4C9E-8470-532C6B75CB7A @default.
- Q92128926 P2860 Q92128926-3F34944F-BA5A-4DFE-940B-F7B9C06D634F @default.
- Q92128926 P2860 Q92128926-44954775-4183-45CE-B340-D7B717580B8A @default.
- Q92128926 P2860 Q92128926-545D1B45-0CB0-4F85-B16B-7D0BF7715D35 @default.
- Q92128926 P2860 Q92128926-56B848AD-8499-411B-B20A-287CAB0CDB16 @default.
- Q92128926 P2860 Q92128926-6C9A3296-0A77-4BB3-86BB-07469AC069F0 @default.
- Q92128926 P2860 Q92128926-6EA39103-E8EA-446A-B310-559D2854000B @default.
- Q92128926 P2860 Q92128926-70AEC34E-DCA6-4D62-B60C-5B9F37A074E7 @default.
- Q92128926 P2860 Q92128926-81E00E9C-76B9-4AA9-BBA2-18194C967FCF @default.
- Q92128926 P2860 Q92128926-B1218C4D-869C-43EF-8D9F-9E99A4A46723 @default.
- Q92128926 P2860 Q92128926-D0209E34-DEB6-47EC-BC2D-38730FD78D15 @default.
- Q92128926 P2860 Q92128926-F41853CA-0A3D-4A52-B980-7A621497D481 @default.
- Q92128926 P304 Q92128926-1A1717EE-EA06-4AF1-A8AA-D4A21A038339 @default.
- Q92128926 P31 Q92128926-B674A35E-79CA-4478-A375-026F2751C7F8 @default.
- Q92128926 P356 Q92128926-08C5E711-55EB-4233-8A76-A580D9A048F5 @default.
- Q92128926 P433 Q92128926-2485E6A2-9AFF-47D1-B719-64B1CE584E92 @default.
- Q92128926 P478 Q92128926-573EC047-DE2A-4E05-ADA8-948D427BDD3D @default.
- Q92128926 P50 Q92128926-C37F5F49-E1FC-45D6-9C03-1A884244C7ED @default.
- Q92128926 P577 Q92128926-B3DFCC58-9597-4936-8B45-B8ACB4CBC987 @default.
- Q92128926 P698 Q92128926-ACC52808-61DC-4E6A-9EF9-EF7735EB8F5A @default.
- Q92128926 P932 Q92128926-FBC7A7AD-AA75-41FB-B7AD-B44ED1EFC950 @default.
- Q92128926 P356 JDI.13075 @default.
- Q92128926 P698 31102326 @default.
- Q92128926 P1433 Q28207066 @default.
- Q92128926 P1476 "Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study" @default.
- Q92128926 P2093 "Feng Wang" @default.
- Q92128926 P2093 "Jian Hua Ma" @default.
- Q92128926 P2093 "Li Xin Shi" @default.
- Q92128926 P2093 "Li Ying Du" @default.
- Q92128926 P2093 "Lu Lu Chen" @default.
- Q92128926 P2093 "Quan Min Li" @default.
- Q92128926 P2093 "Xiao Min Liu" @default.
- Q92128926 P2093 "Yong Quan Shi" @default.
- Q92128926 P2860 Q26859746 @default.
- Q92128926 P2860 Q31082841 @default.
- Q92128926 P2860 Q33960291 @default.
- Q92128926 P2860 Q34661985 @default.
- Q92128926 P2860 Q37345660 @default.
- Q92128926 P2860 Q37412792 @default.
- Q92128926 P2860 Q42671884 @default.
- Q92128926 P2860 Q47403253 @default.
- Q92128926 P2860 Q47771162 @default.
- Q92128926 P2860 Q48263525 @default.
- Q92128926 P2860 Q48264152 @default.
- Q92128926 P2860 Q48273566 @default.
- Q92128926 P2860 Q83902220 @default.
- Q92128926 P2860 Q88512145 @default.
- Q92128926 P304 "142-150" @default.
- Q92128926 P31 Q13442814 @default.
- Q92128926 P356 "10.1111/JDI.13075" @default.
- Q92128926 P433 "1" @default.
- Q92128926 P478 "11" @default.
- Q92128926 P50 Q87110565 @default.
- Q92128926 P577 "2019-06-13T00:00:00Z" @default.
- Q92128926 P698 "31102326" @default.
- Q92128926 P932 "6944837" @default.